On May 22nd and 23rd 2008, Dr. Alex Shneider gave two oral presentations at the 2008 Immunopotentiators of Modern Vaccines Conference. This regular international conference on vaccine adjuvants and methods to enhance vaccine efficiency brings together industry leaders from big pharmaceutical companies, small biotech companies as well as academia. The oral presentations reflected Cure Lab's two technologies on enhancing the efficiency of recombinant vaccines. Cure Lab was the only company at the conference presenting more than one new invention. The talks generated interest among potential industry and academic collaborators.